| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Torben Nielsen CEO | XSTO Exchange | SE0011231158 ISIN |
| Sweden Country | 200 Employees | 6 May 2022 Last Dividend | 1 Jun 2018 Last Split | - IPO Date |
Boule Diagnostics AB (publ) is a key player in the global blood diagnostics market, offering a comprehensive suite of products aimed at enhancing medical diagnostics. Founded in 1956, the company has established a robust presence across various continents, including the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. Headquartered in Spånga, Sweden, Boule Diagnostics focuses on developing, manufacturing, and marketing precision instruments and consumable products for blood analysis. Catering primarily to small and medium-sized hospitals, clinics, laboratories, veterinary clinics, and diagnostics companies, the firm stands out for its dedication to advancing hematology diagnostics through innovation and quality.